CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer

~53 mi. (Latina, Italy, +64 more cities)

A.S.L. LT - Ospedale Santa Maria Goretti

ER Positive, +1 more biomarker

Breast Carcinoma

anastrozole, +2 more drugs

hormone therapy

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

~80 mi. (Pozzuoli, Italy, +226 more cities)

Presidio Ospedaliero S. Maria Delle Grazie-U.O.C. ONCOLOGIA ( Site 0802)

Prostate Adenocarcinoma

enzalutamide, +1 more drug

hormone therapy, +1 more type

Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)

~80 mi. (Pozzuoli, Italy, +93 more cities)

Presidio Ospedaliero Santa Maria delle Grazie ( Site 0599)

Bladder Carcinoma, +1 more condition

cisplatin, +4 more drugs

chemotherapy, +3 more types

A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

~92 mi. (Naples, Italy, +192 more cities)

University of Naples Federico II

ER Positive, +1 more biomarker

Breast Carcinoma

abemaciclib, +1 more drug

hormone therapy, +1 more type

Pembrolizumab/Vibostolimab Coformulation (MK-7684A) or Pembrolizumab/Vibostolimab Coformulation Plus Docetaxel Versus Docetaxel for Metastatic Non Small Cell Lung Cancer (NSCLC) With Progressive Disease After Platinum Doublet Chemotherapy and Immunotherapy (MK-7684A-002)

~92 mi. (Naples, Italy, +76 more cities)

Azienda Ospedaliera Dei Colli-U.O.C Pneumologia Oncologica DH PNL ONC ( Site 1308)

Non-Small Cell Lung Carcinoma

docetaxel, +1 more drug

chemotherapy, +1 more type

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL) or Pancreatic Neuroendocrine Tumor (pNET) (MK-6482-015)

~92 mi. (Naples, Italy, +29 more cities)

University of Naples Federico II-Dipartimento di Medicina Clinica e Chirurgia ( Site 0704)

Pancreatic Neuroendocrine Tumor, +1 more condition

belzutifan

targeted therapy

A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

~92 mi. (Naples, Italy, +44 more cities)

National Cancer Institute

BCL2 Fusion, +2 more biomarkers

Diffuse Large B-Cell Lymphoma, +3 more conditions

cisplatin, +5 more drugs

chemotherapy, +3 more types

A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)

~98 mi. (Rome, Italy, +144 more cities)

Fondazione Policlinico Universitario A. Gemelli ( Site 1414)

Clear Cell Renal Cell Carcinoma

belzutifan, +3 more drugs

immunotherapy, +1 more type

Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)

~98 mi. (Rome, Italy, +147 more cities)

Istituto Nazionale Tumori Regina Elena ( Site 0540)

Cervical Adenocarcinoma, +2 more conditions

brachytherapy, +3 more drugs

chemotherapy, +2 more types

A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)

~98 mi. (Rome, Italy, +127 more cities)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Università Cattolica /ID# 214910

Acute Myeloid Leukemia

azacitidine, +2 more drugs

chemotherapy

Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

~98 mi. (Rome, Italy, +189 more cities)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Università Cattolica /ID# 219087, +1 more facility

del(11)(q10), +27 more biomarkers

Myelofibrosis Transformation in Essential Thrombocythemia, +2 more conditions

navitoclax, +1 more drug

targeted therapy

Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis

~98 mi. (Rome, Italy, +165 more cities)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Università Cattolica /ID# 219083

del(11)(q10), +27 more biomarkers

Myelofibrosis

navitoclax, +1 more drug

targeted therapy